Workflow
Zheng Quan Ri Bao
icon
Search documents
久立特材:长期深耕于油气、电力和高端设备制造等领域
Zheng Quan Ri Bao· 2026-02-11 11:11
证券日报网讯 2月11日,久立特材在互动平台回答投资者提问时表示,公司作为专业的工业用不锈钢管 及特种合金管材、管件、棒材、线材、丝材及管道预制件供应商,长期深耕于油气、电力和高端设备制 造等领域,提供多样化的产品规格,其中公司光热领域产品主要用于集热器的集热管和输送用管等。当 前,在国家大力推动能源转型的背景下,包括光热发电在内的新能源、新材料产业对高性能材料的需求 正逐渐增加,公司也非常关注新兴技术的发展动态,以积极且务实的态度去了解和探索,同时结合行业 实际进展,审慎布局技术储备与产品研发。 (文章来源:证券日报) ...
红日药业:始终将提升内在价值与实现可持续发展作为市值管理的根本依托
Zheng Quan Ri Bao· 2026-02-11 11:11
证券日报网讯 2月11日,红日药业在互动平台回答投资者提问时表示,公司强化完善内控制度建设,做 好内控保障发展的目的。完善内控机制建设和风险管理体系建设,坚持把完善制度作为防范风险的有效 手段,覆盖相关业务风险,逐步建立授权有限、权责明确、相互牵制、相互协调的保障机制和防范风险 的内控机制,为企业经营管理定期开展对管理人员以及基层员工进行内控、合规以及廉洁等方面的教 育,提高管理层公司治理水平,提升全体员工风险防范意识,突出不仅要制定好更要执行好的目标,强 化风险责任追究的举措,违规行为连带追责,倒逼责任落实。公司始终将提升内在价值与实现可持续发 展作为市值管理的根本依托,并持续推进以下实质性工作:一是聚焦主业经营,提升盈利能力;二是强 化公司治理与透明度;三是加强投资者沟通。公司将持续努力,积极推动公司价值获得市场认可。 (文章来源:证券日报) ...
精测电子:关于控股股东、实际控制人部分股权解除质押的公告
Zheng Quan Ri Bao· 2026-02-11 11:11
(文章来源:证券日报) 证券日报网讯 2月11日,精测电子发布公告称,公司控股股东、实际控制人彭骞于2月10日将1,000, 000股解除质押。 ...
爱博医疗:公司聚焦主业,不断拓宽医疗健康领域的布局
Zheng Quan Ri Bao· 2026-02-11 11:11
Group 1 - The company focuses on its core business while continuously monitoring and exploring new technologies and markets [2] - The company aims to expand its layout in the healthcare sector [2]
宝泰隆:截至2025年9月30日,公司股东人数为83064户
Zheng Quan Ri Bao· 2026-02-11 11:11
Group 1 - The core point of the article is that Baotailong has reported an increase in the number of shareholders, reaching 83,064 as of September 30, 2025 [2]
博隆技术:截至2026年2月10日,公司股东总数为9949户
Zheng Quan Ri Bao· 2026-02-11 11:11
Group 1 - The core point of the article is that Bolong Technology reported a total of 9,949 shareholders as of February 10, 2026 [2]
美亚光电:截至2月10日收盘,公司股东数为28256户
Zheng Quan Ri Bao· 2026-02-11 11:11
Group 1 - The core point of the article is that Meiya Optoelectronics responded to investor inquiries, revealing that as of February 10, the number of shareholders is 28,256 [2] Group 2 - The information was disclosed on an interactive platform, indicating the company's transparency in communication with investors [2] - The data is based on documents from the China Securities Depository and Clearing Corporation [2]
爱博医疗:将继续以多元方式提升公司价值,切实回报股东
Zheng Quan Ri Bao· 2026-02-11 11:11
Core Viewpoint - Aibo Medical emphasizes that its stock price fluctuations in the secondary market are influenced by multiple factors, including macroeconomic conditions, industry cycles, and market sentiment, while the company aims to enhance its value through various means and effectively return value to shareholders [2] Group 1: Company Strategy - The company has established a good reputation among doctors and patients for its multiple artificial lens products, which are backed by outstanding technological advantages [2] - Aibo Medical plans to actively seize market opportunities to continuously increase its market share [2]
科前生物:上市公司股价受宏观经济形势、政策变化、市场情绪等多重因素综合影响
Zheng Quan Ri Bao· 2026-02-11 11:11
证券日报网讯 2月11日,科前生物在互动平台回答投资者提问时表示,上市公司股价受宏观经济形势、 政策变化、市场情绪等多重因素综合影响。公司将坚定秉持高质量发展理念,持续加大研发投入,不断 提升经营发展能力,努力回馈投资者。 (文章来源:证券日报) ...
微电生理:2025年年度业绩快报
Zheng Quan Ri Bao· 2026-02-11 11:09
Group 1 - The core viewpoint of the article is that Microelectrophysiology announced its projected financial performance for 2025, indicating a positive growth trajectory in revenue and net profit [2] - The company expects to achieve an operating revenue of 464.53 million yuan in 2025, representing a year-on-year growth of 12.43% [2] - The net profit attributable to the parent company is projected to be 51.15 million yuan [2]